Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$204.81 - $262.19 $532,506 - $681,694
2,600 New
2,600 $533,000
Q3 2022

Nov 14, 2022

BUY
$204.81 - $262.19 $532,506 - $681,694
2,600 New
2,600 $533,000
Q1 2022

May 16, 2022

BUY
$259.82 - $298.18 $25,982 - $29,818
100 Added 1.54%
6,600 $1.74 Million
Q4 2021

Feb 14, 2022

BUY
$271.6 - $314.21 $1.77 Million - $2.04 Million
6,500 New
6,500 $2.04 Million

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $20.6B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Point72 Hong Kong LTD Portfolio

Follow Point72 Hong Kong LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

News

Stay updated on Point72 Hong Kong LTD with notifications on news.